Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

Figure 7

Efficacy of molecular models for poor prognosis in OV patients.

(a)

(b)

(c)

(d)

(e)

(f)